A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy

Published:2015-05 Issue:5 Volume:135 Page:1275-1282.e6
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Narisety Satya D.,Frischmeyer-Guerrerio Pamela A.,Keet Corinne A.,Gorelik Mark,Schroeder John,Hamilton Robert G.,Wood Robert A.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference22 articles.

1. Epidemiology of food allergy;Sicherer;J Allergy Clin Immunol,2011

2. US prevalence self-reported peanut, tree nut, and sesame allergy: 11-year follow-up;Sicherer;J Allergy Clin Immunol,2010

3. National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006;Liu;J Allergy Clin Immunol,2010

4. Trends in allergic conditions among children: United States 1997-2011;Jackson;NCHS Data Brief,2013

5. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up;Sicherer;J Allergy Clin Immunol,2010

Cited by 218 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Food Allergen Immunotherapy in the Treatment of Patients with IgE-Mediated Food Allergy;Medicina;2024-01-09

2. Immunothérapies épicutanées et sublinguales : efficacité, tolérance et place dans la prise en charge de l’allergie alimentaire;Revue Française d'Allergologie;2024-01

3. Gut microbiota and fecal metabolites in sustained unresponsiveness by oral immunotherapy in school-age children with cow's milk allergy;Allergology International;2024-01

4. Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial;Journal of Allergy and Clinical Immunology;2024-01

5. Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy;Allergy;2023-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3